Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Observational × Caspofungin × Clear all

Status

Sponsor Class

Study Type

Interventional 4 Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 1

Interventions

Surveys and Questionnaires 241 Blood Specimen Collection 128 Gene Expression Profiling 86 Interviews as Topic 74 Immunohistochemistry 66 Polymerase Chain Reaction 55 Surgical Procedures, Operative 52 Microarray Analysis 49 Magnetic Resonance Spectroscopy 49 Radiotherapy 45 Flow Cytometry 43 Amplified Fragment Length Polymorphism Analysis 41 Drug Therapy 40 Observation 36 Biopsy 35 Reverse Transcriptase Polymerase Chain Reaction 34 Data Collection 32 Bevacizumab 32 Psychiatric Rehabilitation 26 Therapeutics 24 Nivolumab 24 Sorafenib 23 In Situ Hybridization, Fluorescence 23 palbociclib 22 Neoadjuvant Therapy 22 enzalutamide 21 Focus Groups 21 Docetaxel 21 Rituximab 20 Paclitaxel 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01686607 2024-10-21

MYCOS

Astellas Pharma Inc

40,110 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡